As the understanding of the molecular basis of disease grows, so will the availability of novel tests that will offer disease screening and risk assessment, guide therapy selection, and monitor therapy response in individual patients. The Veranex platform enables innovators in clinical diagnostics and laboratory services by developing strategic approaches to assay development, quality system adherence, regulatory strategy and submission, and market access and reimbursement. In the world of value-based healthcare, diagnostics are poised to play an outsized role in delivering clinical and economic impact. This presents an extraordinary opportunity that innovators must be prepared to capture.

Clinical Areas and Platforms:

  • Anatomic pathology
  • Autoimmune diseases
  • Cardiovascular
  • Carrier screening
  • Clinical chemistry
  • Digital pathology
  • Immunoassay
  • Infectious disease
  • Informatics/AI solutions
  • Inherited and rare diseases
  • Liquid biopsy
  • Mass spectrometry
  • Metabolic
  • NGS/targeted and CGP/WGS/WES
  • Neurology
  • Oncology
  • PCR
  • Point of care